Stockholders' Equity | 10. Stockholders’ Equity The changes in stockholders’ equity for the prior year comparable period are as follows: Additional Accumulated Common Stock Paid-in Treasury Stock Comprehensive Retained Shares Amount Capital Shares Amount Loss Earnings Total Balance at September 30, 2022 35,724,057 $ 36 $ 258,275 ( 3,813,199 ) $ ( 62,554 ) $ ( 10,285 ) $ ( 30,936 ) $ 154,536 Net income — — — — — — 3,967 3,967 Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units 190,119 — 495 — — — — 495 Taxes paid associated with net settlement of stock compensation awards ( 14,536 ) — ( 244 ) — — — — ( 244 ) Common stock repurchased — — — ( 531,819 ) ( 7,199 ) — — ( 7,199 ) Stock compensation expense — — 2,126 — — — — 2,126 Foreign currency translation and other — — — — — 1,273 — 1,273 Balance at December 31, 2022 35,899,640 $ 36 $ 260,653 ( 4,345,018 ) $ ( 69,754 ) $ ( 9,012 ) $ ( 26,970 ) $ 154,953 Net income — — — — — — 4,245 4,245 Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units 184,791 — — — — — — — Taxes paid associated with net settlement of stock compensation awards ( 34,713 ) — ( 492 ) — — — — ( 492 ) Common stock repurchased — — — ( 749,903 ) ( 9,814 ) — — ( 9,814 ) Common stock surrendered in the exercise of stock options — — 18 ( 1,420 ) ( 18 ) — — — Stock compensation expense — — 1,939 — — — — 1,939 Foreign currency translation — — — — — 243 — 243 Balance at March 31, 2023 36,049,718 $ 36 $ 262,118 ( 5,096,341 ) $ ( 79,586 ) $ ( 8,769 ) $ ( 22,725 ) $ 151,074 Stock Compensation Incentive Plans The Company has several incentive plans under which stock options, restricted stock units (RSUs), restricted stock awards (RSAs), and cash-settled stock appreciation rights (SARs) have been issued, including the Third Amended and Restated 2006 Omnibus Long-Term Incentive Plan, as amended (LTIP), and a plan and private placement issuances related to the Company’s acquisition of Machinio and Bid4Assets. The Machinio plan expired according to its terms on April 17, 2024 . During the six months ended March 31, 2024, the Company's shareholders approved an amendment to the LTIP to increase the number of shares of common stock from 20,300,000 to 22,800,000 , reserved for issuance for exercises of stock options and vesting of RSUs under these plans. Vesting of RSU s count as 1.5x shares against the plan reserves. As of March 31, 2024 , 2,415,326 shares of common stock remained available for use under the LTIP. Stock Compensation Expense The table below presents the components of share-based compensation expense (in thousands): Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 Equity-classified awards: Stock options $ 524 $ 524 $ 1,024 $ 999 RSUs & RSAs 1,819 1,415 3,567 3,066 Total Equity-classified award 2,343 1,939 4,592 4,065 Liability-classified awards: SARs — — — ( 44 ) Total stock compensation expense: $ 2,343 $ 1,939 $ 4,592 $ 4,021 The table below presents the components of share-based compensation expense by line-item within our Condensed Consolidated Statements of Operations (in thousands): Three Months Ended March 31, Six Months Ended March 31, 2024 2023 2024 2023 Stock-compensation expense by function Technology and operations $ 350 $ 336 $ 680 $ 592 Sales and marketing 637 659 1,275 1,168 General and administrative 1,356 944 2,637 2,261 Total stock compensation expense: $ 2,343 $ 1,939 $ 4,592 $ 4,021 Stock Options and RSUs & RSAs The following table presents stock option and RSUs & RSAs grant activity: Six Months Ended March 31, 2024 Stock Options granted: Options containing only service conditions: 125,955 Weighted average exercise price $ 18.00 Weighted average grant date fair value $ 9.03 Options containing performance conditions: 125,955 Weighted average exercise price $ 18.00 Weighted average grant date fair value $ 9.03 RSUs & RSAs granted: RSUs & RSAs containing only service conditions: 364,446 Weighted average grant date fair value $ 19.03 RSUs & RSAs containing performance conditions: 303,610 Weighted average grant date fair value $ 19.29 The stock options and RSUs & RSAs containing only service conditions will vest over a four-year service period. The stock options and RSUs & RSAs containing performance conditions will vest upon the achievement of specified financial targets of the Company, a segment, or a division of a segment. Vesting is measured on the first day of each fiscal quarter over the three-year terms of the awards, starting with the first fiscal quarter after the first anniversary of the grant date. The range of assumptions used to determine the fair value of stock options using the Black-Scholes option-pricing model during the six months ended March 31, 2024, were as follows: Six Months Ended March 31, 2024 Dividend yield — Expected volatility 59.08 % - 60.83 % Risk-free interest rate 3.83 % - 3.88 % Expected term 4.5 - 5.0 years Share Repurchase Program From time to time, we may be authorized to repurchase issued and outstanding shares of our common stock under a share repurchase program approved by our Board of Directors. Share repurchases may be made through open market purchases, privately negotiated transactions or otherwise, at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The repurchase program may be discontinued or suspended at any time and will be funded using our available cash. As of September 30, 2023, the Company had $ 17.0 million of remaining share repurchase authorization through December 31, 2025. The Company repurchased 473,953 shares for $ 7.9 million, and 542,645 shares for $ 9.0 million, during the three and six months ended March 31, 2024, respectively. As of March 31, 2024 , the Company had $ 8.0 million of remaining authorization to repurchase shares through December 31, 2025. Other Share Repurchases Separate from the share repurchase program, our stock incentive plans allow for participants to exercise stock options by surrendering shares of common stock equivalent in value to the exercise price due. Any shares surrendered to the Company in this manner are not available for future grant. During the six months ended March 31, 2024 and 2023, participants surrendered 0 and 1,420 shares of common stock, respectively, in connection with the exercise of stock options. |